- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A LinkedIn launch post and linked press release for Xonvea were found to include product claims and be disseminated to the public,…
MSD gave an inter-company undertaking to withdraw materials wrongly showing alogliptin with a black triangle, but an outdated Januvia leavepiece was still…
Otsuka voluntarily admitted errors/omissions in prescribing information across four medicines. PMCPA found breaches focused on Samsca PI being inconsistent with the SPC,…
GSK’s Relvar Ellipta Pulse ad was challenged on generic name placement and a “25% more patients improve asthma control” claim. The PMCPA…
After inter-company dialogue, Ipsen’s “Dysport – a toxin with a long-lasting effect” messaging was found to imply an unsubstantiated duration advantage. Appeal…
A BMJ-hosted Alprolix advert used a bold safety headline (“No anaphylaxis or allergic reactions”) that was contradicted by the bullets/footnote and inconsistent…
A BMJ website “tile” showed the Dovato brand name but no generic name, no PI (or one-click link), no black triangle (when…
Anonymous complaint that BPL’s LinkedIn post sharing a Telegraph article promoted an unlicensed/off-label Covid-19 therapy to the public. Panel ruled no breach…
A health professional said Sobi’s webinar title “Beyond the National Services Division Review” was misleading and implied NSD endorsement. The Panel found…
Vitamin D Vitality app previews on Google Play showed InVita D3 and PI before download. Panel ruled this advertised a POM to…
Nilemdo FOC scheme material continued to show Praluent with a black triangle after it was removed from the SPC. PMCPA found the…
PMCPA ruled Takeda’s ASH highlights webinar was not genuine scientific exchange and promoted ixazomib for an unlicensed frontline myeloma indication. Breaches of…
Ever Pharma’s Dacepton leavepieces breached the ABPI Code for misleading stability and cost-saving claims that omitted microbiological contamination caveats from the SPC.…
Sanofi emails to GP customers and an NHS manager suggested QIVe orders were “fully reimbursable” and criticised local NHS interpretation. PMCPA found…
Anonymous health professional alleged Sanofi promoted Suliqua for use alongside basal insulin, risking overdose. Panel found insufficient evidence and ruled no breach…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.